ArticleCureus2026

Achieving Rapid Remission With Guselkumab in a Moderately Active Ulcerative Colitis Patient With High Infectious Risk and Inadequate Response to Advanced Therapy: A Case Report.

Nozomi Furuichi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.